Lifecore Biomedical, Inc. (LFCR) — Stock Score Summary

Lifecore Biomedical, Inc. (LFCR) has a MoatMap StockRank of 16/100 based on Quality (33/100), Value (37/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL. While Lifecore operates as a CDMO, which superficially aligns with our CDMO Pricing Power theme, the company has been plagued by severe financial restatements, high leverage, and operational instability. This violates the Buffett and Terry Smith requirements for capital allocational sanity and predictable owner earnings.

Lifecore Biomedical, Inc. is a fully integrated cGMP manufacturer and supplier of fermentation-derived hyaluronic acid (HA), and a contract development and manufacturing organization (CDMO) for sterile fill-finish pharmaceuticals. The company is a leading provider of high-quality HA, benefiting from expertise in fermentation processes and a strong reputation as a CDMO for complex injectable products. Lifecore Biomedical is a vertically integrated biomedical company specializing in hyaluronic acid production and sterile pharmaceutical manufacturing.

Key Financial Metrics

Price$5.66
Market Cap$186M
P/E (Forward)-7.15
Price/Book-15.28
Return on Invested Capital-7.9%
Debt/Equity722.60
Gross Margin31.4%
Operating Margin-13.2%

Lifecore Biomedical, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Lifecore Biomedical, Inc.’s (LFCR) StockRank?
MoatMap’s StockRank for Lifecore Biomedical, Inc. (LFCR) is 16/100, with a Strong Sell signal. It is a composite of Quality (33), Value (37), and Momentum (30) factor ranks across MoatMap’s 19,000+ stock universe.
Does Lifecore Biomedical, Inc. have an economic moat?
Lifecore Biomedical, Inc. (LFCR) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lifecore Biomedical, Inc. a buy, hold, or sell?
MoatMap’s current signal for Lifecore Biomedical, Inc. (LFCR) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Lifecore Biomedical, Inc. in?
Lifecore Biomedical, Inc. (LFCR) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksLFCR deep dive reportAI ChampionsHow we score stocksSense-check another stock